Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

214.49USD
14 Aug 2020
Change (% chg)

$-2.87 (-1.32%)
Prev Close
$217.36
Open
$215.68
Day's High
$217.27
Day's Low
$212.86
Volume
37,833
Avg. Vol
95,584
52-wk High
$221.93
52-wk Low
$95.79

Latest Key Developments (Source: Significant Developments)

Charles River Labs Reports Q4 Non-GAAP Earnings Per Share $2.01
Tuesday, 11 Feb 2020 

Feb 11 (Reuters) - Charles River Laboratories International Inc ::CHARLES RIVER LABORATORIES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS AND PROVIDES 2020 GUIDANCE.Q4 GAAP EARNINGS PER SHARE $1.61.Q4 NON-GAAP EARNINGS PER SHARE $2.01.Q4 REVENUE $691.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $685.3 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $1.83 -- REFINITIV IBES DATA.PROVIDES 2020 GUIDANCE.SEES 2020 REPORTED REVENUE GROWTH OF 13.0% - 14.5%.SEES 2020 NON-GAAP EPS ESTIMATE OF $7.45 - $7.60.SEES 2020 GAAP EPS ESTIMATE $5.20 - $5.35.SEES 2020 ORGANIC REVENUE GROWTH OF 7.75% - 8.75%.SEES 2020 FREE CASH FLOW OF $350 MILLION - $360 MILLION.FY2020 EARNINGS PER SHARE VIEW $7.41 -- REFINITIV IBES DATA.  Full Article

Charles River Labs Announces Fourth-Quarter And Full-Year 2018 Results
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Charles River Laboratories International Inc ::CHARLES RIVER LABORATORIES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS AND PROVIDES 2019 GUIDANCE.Q4 NON-GAAP EARNINGS PER SHARE $1.49.Q4 GAAP EARNINGS PER SHARE $1.21.Q4 REVENUE $601.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $590.8 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $1.40 -- REFINITIV IBES DATA.SEES 2019 GUIDANCE, EXCLUDING CITOXLAB, GAAP EPS $5.05-$5.20.SEES 2019 GUIDANCE, EXCLUDING CITOXLAB, NON-GAAP EPS $6.25-$6.40.SEES 2019 REPORTED REVENUE GROWTH EXCLUDING CITOXLAB OF10.5% - 12.0%.SEES 2019 GUIDANCE, EXCLUDING CITOXLAB,FREE CASH FLOW $320- $330 MILLION.FY2019 EARNINGS PER SHARE VIEW $6.34 -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $2.49 BILLION -- REFINITIV IBES DATA.  Full Article

Charles River Laboratories Signs Binding Offer To Acquire Citoxlab
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Charles River Laboratories International Inc ::CHARLES RIVER LABORATORIES SIGNS BINDING OFFER TO ACQUIRE CITOXLAB.TRANSACTION EXPECTED TO BE ACCRETIVE TO NON-GAAP EPS BY APPROXIMATELY $0.15 IN 2019.DEAL FOR EUR 448 MILLION IN CASH (OR APPROXIMATELY $510 MILLION BASED ON CURRENT EXCHANGE RATES).SIGNED A BINDING OFFER TO ACQUIRE CITOXLAB FOR EUR 448 MILLION IN CASH.PROPOSED ACQUISITION IS EXPECTED TO ADD $115 TO $130 MILLION TO CHARLES RIVER'S 2019 CONSOLIDATED REVENUE.CHARLES RIVER LABORATORIES INTERNATIONAL - PROPOSED DEAL, FEES EXPECTED TO BE FINANCED THROUGH EXISTING REVOLVING CREDIT FACILITY AND CASH.PROPOSED ACQUISITION IS EXPECTED TO ADD APPROXIMATELY $200 MILLION TO 2020 CONSOLIDATED REVENUE.CHARLES RIVER LABORATORIES INTERNATIONAL- DEAL EXPECTED TO BE ACCRETIVE TO NON-GAAP EARNINGS PER SHARE BY ABOUT $0.15 IN 2019 AND AT LEAST $0.35 IN 2020.  Full Article

Atomwise, Charles River Laboratories Form Strategic Alliance
Friday, 11 Jan 2019 

Jan 11 (Reuters) - Atomwise::ATOMWISE AND CHARLES RIVER LABORATORIES FORM A STRATEGIC ALLIANCE TO PROVIDE PREMIER ARTIFICIAL INTELLIGENCE-POWERED DRUG DISCOVERY CAPABILITIES.ATOMWISE - UNDER DEAL, CO TO SUPPORT HIT DISCOVERY, HIT-TO-LEAD, LEAD OPTIMIZATION EFFORTS; CO TO MAKE TECHNOLOGY AVAILABLE FOR MULTIPLE PROJECTS.ATOMWISE - PROJECTS THAT TOTAL POTENTIAL VALUE OF ROYALTIES TO CO WITH SUCCESS IN ALL PROJECTS COULD EXCEED $2.4 BILLION.ATOMWISE - UNDER DEAL, CO TO GET TECHNOLOGY ACCESS FEES, MILESTONE-BASED PAYMENTS & ROYALTIES FROM CLIENTS.  Full Article

Charles River Laboratories Reports Q3 Adj. EPS of $1.53
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Charles River Laboratories International Inc ::ANNOUNCES THIRD-QUARTER 2018 RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $1.53.Q3 GAAP EARNINGS PER SHARE $1.22.Q3 REVENUE $585.3 MILLION VERSUS I/B/E/S VIEW $567.8 MILLION.Q3 EARNINGS PER SHARE VIEW $1.38 -- THOMSON REUTERS I/B/E/S.INTERNATIONAL INC - UPDATES 2018 GUIDANCE.INTERNATIONAL INC SEES FY 2018 GAAP EPS $4.44 - $4.54.INTERNATIONAL INC SEES FY 2018 NON-GAAP EPS $5.87 - $5.97.  Full Article